ATE129236T1 - N-sulphonylindolinderivate, deren herstellung und diese enthaltende arzneimittel. - Google Patents

N-sulphonylindolinderivate, deren herstellung und diese enthaltende arzneimittel.

Info

Publication number
ATE129236T1
ATE129236T1 AT91402123T AT91402123T ATE129236T1 AT E129236 T1 ATE129236 T1 AT E129236T1 AT 91402123 T AT91402123 T AT 91402123T AT 91402123 T AT91402123 T AT 91402123T AT E129236 T1 ATE129236 T1 AT E129236T1
Authority
AT
Austria
Prior art keywords
denotes
alkyl
group
trifluoromethyl
naphthyl
Prior art date
Application number
AT91402123T
Other languages
English (en)
Inventor
Jean Wagnon
Cointet Paul De
Dino Nisato
Claude Plouzane
Claudine Serradeil-Legal
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Application granted granted Critical
Publication of ATE129236T1 publication Critical patent/ATE129236T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT91402123T 1990-07-31 1991-07-30 N-sulphonylindolinderivate, deren herstellung und diese enthaltende arzneimittel. ATE129236T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9009778A FR2665441B1 (fr) 1990-07-31 1990-07-31 Derives de la n-sulfonyl indoline, leur preparation, les compositions pharmaceutiques en contenant.

Publications (1)

Publication Number Publication Date
ATE129236T1 true ATE129236T1 (de) 1995-11-15

Family

ID=9399281

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91402123T ATE129236T1 (de) 1990-07-31 1991-07-30 N-sulphonylindolinderivate, deren herstellung und diese enthaltende arzneimittel.

Country Status (17)

Country Link
EP (1) EP0469984B1 (de)
JP (1) JP3195381B2 (de)
KR (1) KR100211434B1 (de)
AT (1) ATE129236T1 (de)
AU (2) AU645585B2 (de)
CA (1) CA2048139C (de)
DE (1) DE69113911T2 (de)
ES (1) ES2080922T3 (de)
FI (1) FI97224C (de)
FR (1) FR2665441B1 (de)
HU (1) HU220765B1 (de)
IE (1) IE73452B1 (de)
IL (2) IL99012A (de)
NO (1) NO175254C (de)
NZ (1) NZ239182A (de)
PT (1) PT98476B (de)
ZA (1) ZA916031B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338755A (en) * 1990-07-31 1994-08-16 Elf Sanofi N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present
US5481005A (en) * 1990-07-31 1996-01-02 Sanofi N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present
FR2679903B1 (fr) * 1991-08-02 1993-12-03 Elf Sanofi Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant.
WO1995002587A1 (en) * 1993-07-16 1995-01-26 Merck & Co., Inc. Substituted piperazinylcamphor derivatives as oxytocin antagonists
CA2166975C (en) * 1993-07-16 2005-04-05 Mark G. Bock Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists
FR2708606B1 (fr) * 1993-07-30 1995-10-27 Sanofi Sa Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
FR2714378B1 (fr) * 1993-12-24 1996-03-15 Sanofi Sa Dérivés de l'indol-2-one substitués en 3 par un groupe azoté, leur préparation, les compositions pharmaceutiques en contenant.
GB9918684D0 (en) * 1999-08-09 1999-10-13 Novartis Ag Organic compounds
US7312358B2 (en) 2000-10-17 2007-12-25 Laboratoires Serono Sa Pharmaceutically active sulfanilide derivatives
GB0115515D0 (en) * 2001-06-25 2001-08-15 Ferring Bv Oxytocin agonisys
GB0116594D0 (en) 2001-07-06 2001-08-29 Cancer Res Ventures Ltd Therapeutic compounds
IL162615A0 (en) 2001-12-20 2005-11-20 Applied Research Systems Triazole derivatives, their preparation and pharmaceutical compositions containing them
EP2399903A1 (de) * 2002-05-24 2011-12-28 Millennium Pharmaceuticals, Inc. CCR9-Hemmer und Verwendungsverfahren dafür
MXPA05006650A (es) * 2002-12-20 2005-09-30 Cancer Rec Tech Ltd Compuestos de 4-(1-(sulfonil)-1h-indol-2-il)-4-(hidroxi)-ciclohexa-2,5-dienona y analogos de los mismos como agentes terapeuticos.
FR2853650B1 (fr) * 2003-04-10 2006-07-07 Merck Sante Sas Procede de dedoublement d'amines utiles pour le traitement de desordres associes au syndrome d'insulino-resistance
FR2880023B1 (fr) 2004-12-23 2007-02-23 Sanofi Aventis Sa Derives de n-[(4,5-diphenyl-3-alkyl-2-thienyl) methyl] amine leur preparation et leur application en therapeutique
FR2927625B1 (fr) 2008-02-19 2010-03-12 Sanofi Aventis Nouveaux derives de 3-aminoalkyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique
FR2930249B1 (fr) 2008-04-21 2010-05-14 Sanofi Aventis Nouveaux derives de 3-aminoalkyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3838167A (en) * 1972-08-01 1974-09-24 Lilly Co Eli Process for preparing indoles
US4479963A (en) * 1981-02-17 1984-10-30 Ciba-Geigy Corporation 1-Carboxyalkanoylindoline-2-carboxylic acids
DE3705934A1 (de) * 1987-02-25 1988-09-08 Nattermann A & Cie Indolyl-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
GB8820129D0 (en) * 1988-08-24 1988-09-28 Schering Agrochemicals Ltd Fungicides
FR2679903B1 (fr) * 1991-08-02 1993-12-03 Elf Sanofi Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
KR100211434B1 (ko) 1999-08-02
IL99012A0 (en) 1992-07-15
HU912552D0 (en) 1992-01-28
IL114934A0 (en) 1995-12-08
AU8147891A (en) 1992-02-06
IE912696A1 (en) 1992-02-12
NO912970L (no) 1992-02-03
AU645585B2 (en) 1994-01-20
FI97224C (fi) 1996-11-11
AU5047393A (en) 1994-01-13
NZ239182A (en) 1995-07-26
EP0469984B1 (de) 1995-10-18
FR2665441A1 (fr) 1992-02-07
NO175254C (no) 1994-09-21
DE69113911D1 (de) 1995-11-23
CA2048139A1 (en) 1992-02-01
HU220765B1 (hu) 2002-05-28
ZA916031B (en) 1992-04-29
DE69113911T2 (de) 1996-03-28
CA2048139C (en) 2002-02-12
ES2080922T3 (es) 1996-02-16
FR2665441B1 (fr) 1992-12-04
HUT59669A (en) 1992-06-29
JP3195381B2 (ja) 2001-08-06
JPH04234361A (ja) 1992-08-24
FI913614A (fi) 1992-02-01
FI97224B (fi) 1996-07-31
NO912970D0 (no) 1991-07-30
NO175254B (no) 1994-06-13
FI913614A0 (fi) 1991-07-29
EP0469984A3 (de) 1992-03-11
EP0469984A2 (de) 1992-02-05
PT98476B (pt) 1997-10-31
IE73452B1 (en) 1997-06-04
IL99012A (en) 1996-07-23
AU664491B2 (en) 1995-11-16
PT98476A (pt) 1992-05-29
KR920002537A (ko) 1992-02-28

Similar Documents

Publication Publication Date Title
ATE129236T1 (de) N-sulphonylindolinderivate, deren herstellung und diese enthaltende arzneimittel.
AU677852B2 (en) Acetamide derivatives and their use for modifying feeding behavior modifiers
AU6788296A (en) Use of adamantane derivatives for treating diseases of the inner ear
MY110517A (en) Indoline derivatives carrying an amide functional group their preparation and the pharmaceutical compositions in which they are present.
DE3768689D1 (de) N-substituierte 3,4,5,6-tetrahydrophthalimide und deren vorprodukte.
ATE135687T1 (de) Perhydroisoindolderivate, ihre herstellung und diese enthaltende arzneimittel
TW345575B (en) Pharmaceutical composition comprising an inhibitor for ras farnesylation and the preparation of the inhibitor compound
FI943948A (fi) Heterosykliset hiilihappojohdannaiset
ATE376998T1 (de) 1,2-diphenylpyrrol-derivate, ihre herstellung und therapeutische verwendung
GR3033505T3 (en) Indole, indazole and benzisoxazole derivatives as 5-HT1-like agonists.
ATE165332T1 (de) Polyenderivate, diese enthaltende pharmazeutische und kosmetische zusammensetzungen und ihre verwendung
DE69319925T2 (de) Indol-piperazin-derivate als selektive liganden der 5ht1d und 5ht1b receptoren verwendbar als arzneimittel
DK0646110T3 (da) N-substituerede 3-azabicyclo(3.2.0) heptanderivater som neuroleptika
DK0689534T3 (da) Amidderivater som 5-HT1A-ligander
ZA941334B (en) Amide derivative .
BR9506763A (pt) Derivados de carbamoil metil uréia
DE68903893D1 (de) 20,21-dinoreburnamenin-derivate, substituiert in position 15 durch eine aminogruppe und deren salze, verfahren zu deren herstellung und die auf diese weise erhaltenen zwischenverbindungen, deren anwendung als arzneimittel und diese enthaltende pharmazeutische zusammensetzungen.
IL107915A (en) N-substituted azabicycloheptane derivatives and their use as medicaments
UA41868C2 (uk) N-заміщені похідні 3-азабіцикло[3.2.0]гептану
DK0667860T3 (da) Azaspiroalkan-derivater som terapeutiske midler

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee